Susan Perrine is an Oncology physician. OpenAlex indexes 116 publications with 4,323 citations (h-index 34); ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
830 Harrison Ave
Moakley, 3rd Floor
Boston, MA 021182905
Telephone
617-638-6428Registry record last updated 7 Apr 2014.
Clinical trials
- The BENeFiTS Trial in Beta Thalassemia Intermedia
Sponsor: Phoenicia BioScience
- Trial of HQK-1001 in Beta Thalassemia Intermedia in Lebanon
Sponsor: Boston University
- Phase 1/2 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HQK-1001 Administered Daily in Patients With Sickle Cell Disease
Sponsor: HemaQuest Pharmaceuticals Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Emmaus Medical, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
17 NIH research awards on record, funded 1993–2022 per NIH RePORTER. The latest:
- Development of a Clinical Hemoglobin Modulator
Phoenicia Biosciences, Inc.
FY2022$1,630,002R33HL147845 - Development of a Clinical Hemoglobin Modulator
Phoenicia Biosciences, Inc.
FY2021$1,843,809R33HL147845 - Development of a Clinical Hemoglobin Modulator
Phoenicia Biosciences, Inc.
FY2020$1,733,012R33HL147845
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Therapeutic fetal-globin inducers reduce transcriptional repression in hemoglobinopathy erythroid progenitors through distinct mechanisms
Blood Cells Molecules and Diseases
2015 - Targeted Fetal Hemoglobin Induction for Treatment of Beta Hemoglobinopathies
Hematology/Oncology Clinics of North America
2014
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”